Why relief that builds over weeks is a feature, not a flaw.

Relief from a sensitivity toothpaste arrives on a slope rather than at a moment, because neither of its two jobs is finished in one brushing: potassium builds up around the nerve over repeated exposures, and mineral is deposited at the mouth of the tubule in layers far too thin to feel. The wait is not a defect in the product. It is the only stretch of the curve that tells an active ingredient apart from the response to being treated, which is why the consensus protocol for trials in this field asks for eight weeks and a follow-up after them¹. The levels on the S3 Sensitivity Science™ tube are the ones those published trials used: 5% potassium nitrate, and nano-hydroxyapatite at a 10% solution.

What was checked20 peer-reviewed studies, guidance from the Oral Health Foundation and the NHS

Why does the effect build rather than arrive?

Because neither job is done in one go. Potassium acts on how readily the nerve fires, and that only shifts while potassium keeps arriving; hydroxyapatite acts at the mouth of the tubule, and every brush leaves a little more mineral than the one before. Neither mechanism has a switch in it.

The curves say the same thing in numbers. In a twelve-week double-blind placebo-controlled trial of 36 adults, a 5% potassium nitrate paste showed its first fall in scores at week two and significant reductions in cold-air, tactile and subjective sensitivity at weeks four, eight and twelve⁶. In a twelve-week double-blind randomised trial of 120 adults that had no placebo arm, the same active cut cold-water sensitivity by 34% at two weeks and by 79% at twelve⁷. Hydroxyapatite starts earlier and still climbs: in a four-week double-blind randomised trial of 105 adults, a 15% nano-hydroxyapatite paste beat both a fluoride paste and a placebo at two weeks, and by more at four⁸. The eight-week nano-hydroxyapatite trial most often quoted for that curve — a double-blind randomised trial of 85 adults, funded by Sangi, which made the test pastes — reports a steady fall at every two-week reading, but it had no negative control arm at all, so its curve cannot tell the active apart from everything else that happens when someone joins a trial⁹.

Every row is an active ingredient or a control, not a finished tube. S3's own testing is a consumer trial rather than a time-course study of this kind, so it has no row here; how these readings are made at all is a separate question, answered on the page about how desensitising toothpastes are tested.

How much of those first two weeks is the toothpaste?

Less of it than you would like. In a split-mouth, subject-blind randomised study of 22 adults, a periodontal dressing with no desensitising active in it, laid over the sensitive teeth, cut pain by 95% to a heat stimulus and by 85% to an evaporative one, against the untreated quadrant in the same mouth¹⁰. In a six-month placebo-controlled crossover trial of 35 patients, water alone cut air-blast pain by 20% immediately after application and by 36% at six months¹¹. In a six-arm randomised trial of 164 adults, the plain fluoride toothpaste that served as the control improved the Schiff score and the pain score too — not at four weeks, but by week eight¹². And in a six-week double-blind trial of 120 adults, potassium nitrate, strontium acetate and a plain fluoride paste all improved, with no significant difference between them at any point¹³.

There is a design reason as well as a psychological one. These trials recruit only teeth that already score badly — the entry window in one three-day trial of 120 adults, whose funding is not stated in the record, was a Schiff score of two or three and a probe response between 10 g and 50 g¹⁴ — and a measurement taken at its worst tends to read better next time whatever you do to it. That is what a control arm is for, and it is why a before-and-after number with no control arm tells you very little about the paste.

Nobody has put a size on that response for the category as a whole. The search behind this page found meta-analyses comparing desensitising toothpastes with placebo, which pool the gap between the two arms, and no pooled estimate of how far the placebo arm itself moves. So this page will not give you a fraction: what the evidence supports is that the effect is real and not small, not that it accounts for some particular share of your first fortnight.

A second gap matters more to someone standing at the bathroom sink. How large a change has to be before a person notices it has been worked out for one measure only, and it is not the measure that gets reported. In a validation study that pooled 311 participants from three earlier trials, funded by GlaxoSmithKline Consumer Healthcare and co-authored by two of its scientists, the smallest important difference on the Dentine Hypersensitivity Experience Questionnaire came out between 22 and 39 points¹⁵. Nothing equivalent has been published for the Schiff air score or for a pain scale. When that threshold was applied to a real eight-week trial of 75 adults, 50.7% improved on the clinical measure and 22.7% improved enough on the questionnaire for the change to register⁴. The examiner's number and your own verdict are answering different questions, and only one of them is the question you actually asked.

Do different actives have different clocks?

Yes, and one systematic review has grouped them by the clock rather than by the winner: 74 randomised trials, arranged by the follow-up window in which each treatment's reduction first reached significance².

The trial that put three actives through one protocol makes the same point from the other end. In a double-blind randomised trial of 120 adults funded by Procter & Gamble, with company staff in seven of the eight author positions, a stannous fluoride paste and an experimental oxalate paste beat the control on both measures at day three, while the potassium nitrate paste did not separate from the control on the tactile measure until week two¹⁶. In the same industry-funded trial, the week-eight improvement over control was 57% for stannous fluoride, 47% for oxalate and 44% for potassium nitrate, and the differences between the three actives were not significant¹⁶. A bioactive glass runs earlier again: in an examiner-blind randomised trial of 215 adults, funded by Haleon and written largely by its employees, a 5% calcium sodium phosphosilicate toothpaste beat a plain fluoride paste from day three and kept climbing to day 56¹⁷. The clock for each active on its own is set out on the pages for potassium nitrate and for nano-hydroxyapatite.

Set against all of that, a network meta-analysis of 30 randomised trials found no significant difference between potassium toothpaste and placebo, and none between fluoride toothpaste and placebo either, while ranking nano-hydroxyapatite first on probability at two and four weeks³. Both readings are in the literature and this page will not average them. In a placebo-controlled trial a potassium paste usually separates from its control by week eight⁶; pooled into one network with every comparable trial, that separation can vanish³. The disagreement is real, it is about how well potassium works rather than how quickly, and nobody has settled it.

What does fast relief cost?

Durability, wherever anyone has bothered to measure both ends. Hydroxyapatite applied once in the surgery was ahead of water and of no treatment at every reading from day one to week four in a randomised trial of 45 patients; by week eight there was nothing left to separate the four groups, even though the paper itself billed the agent as a lasting fix⁵. The laser arm of a randomised trial in 82 adults tells the same story in miniature: after two sessions and a fortnight of maintenance it retained 3% of its effect, which did not reach significance, against 33% retained by the nano-carbonate apatite toothpaste in the same trial¹⁸.

A three-day trial can only answer a three-day question. The 8% arginine paste that produced a large drop in one such trial of 120 adults, whose funding is not stated in the record, was rubbed on by fingertip and massaged in for a minute before any brushing began, and the trial stopped on the third day¹⁴. That design shows what a single application can do to a tooth on the day. It cannot show what a tube does to a mouth over a season, because it never looked.

What happens if you stop?

Less than the warnings suggest, and much less than anyone has properly measured. When every group in the industry-funded eight-week trial above moved to the plain control paste for three weeks, all three actives still held a significant benefit at week eleven — between 68% and 83% of the cold-air benefit they had at week eight — and by then they no longer differed from one another¹⁶. In a twelve-week double-blind randomised trial of 129 adults funded by Hawley & Hazel, four of whose six authors are its employees, the air-stimulus advantage of a hydroxyapatite-citrate paste was still there four weeks after the paste was put away, while the tactile advantage had largely gone¹⁹. Over 24 weeks, using a bioactive-glass paste in two eight-week blocks was no different from using it without a break, in a trial of 76 adults funded by GSK Consumer Healthcare and first-authored by one of its employees; the authors describe the improvements from either regimen as small²⁰.

None of that means the effect keeps going. It means only that it does not stop on the day you do, and that nobody has followed anyone far enough to say what happens after a few weeks off. What daily care can realistically achieve over years is a bigger question, and it has its own guide; what specifically happens after a potassium nitrate paste is put down is answered separately.

When should you judge S3, and what should you judge it against?

At two to four weeks, brushing twice a day, against how the same teeth felt in the same conditions before you started. That window is not a convenience: it is where the trials of the actives in the tube take their readings, and where the consensus protocol for this field expects an effect to be visible¹. Unlike a single-active paste bought for a bad fortnight, S3 is the toothpaste you use every day, and it is sold with a money-back guarantee on the terms published with the product.

Judge it honestly while you are at it. Some of what you feel in the first fortnight belongs to having started something, so the four-week reading is the one that carries information, which is precisely why the trials look there instead of on day one. The levels are the part you can check for yourself: 5% potassium nitrate and 10% nano-hydroxyapatite are inclusion levels of the ingredient as supplied, and the active hydroxyapatite content is lower than either figure.

Patience also has a limit, and it is not ours to set. The Oral Health Foundation tells people to see a dentist when the pain is severe, when only one tooth is involved, when it arrives suddenly, or when the sensitivity has gone on for more than a few weeks²¹. Those are the patterns that patience does not fix.

Frequently asked questions

How long before S3 should be working?

Give it two to four weeks of brushing twice a day before you decide. That is the window the published trials of potassium nitrate and hydroxyapatite use for their own readings, and it is the window S3 is built around. There is a money-back guarantee if it does not get there, on the terms published with the product.

The honest half of the answer is that part of any change you notice in the first fortnight belongs to having started a treatment at all, which several controlled trials have shown clearly¹⁰¹². The four-week reading is the one that means something.

If I feel better after three days, is it working?

Possibly, and the three-day reading cannot tell you. A dressing with no active in it, water, and plain fluoride toothpaste have all produced measurable improvement in controlled trials¹⁰¹¹¹², so an early change is not evidence about the active in your tube either way.

Keep brushing and re-ask the question at week four. Nothing is lost by waiting, and the reading you get then is the one the trials would recognise; the practical version of that advice, for someone who has just switched paste, is on the page about how long to give a new one.

Why do trials run for eight weeks?

Because the consensus protocol for dentine hypersensitivity says so, and it says so for a reason: eight weeks is long enough for the placebo and regression components to flatten out and leave the active's contribution visible, with a follow-up afterwards to see whether the change holds¹.

The one large trial that measured three actives at day three and again at weeks two, four and eight was industry-funded, and its own week-eight reading contradicts its day-three one: the ordering at day three had gone by week eight, when the three actives no longer differed significantly¹⁶.

Is a toothpaste that works in a day better?

Nothing sold in a tube reached significance inside seven days in the systematic review that grouped treatments by their follow-up window; the ones that did are all applied by a dentist². Where an in-surgery treatment has been followed for long enough, the early advantage has faded: hydroxyapatite applied in the chair was ahead of water and no treatment from day one to week four and level with them by week eight⁵.

When is "give it time" the wrong advice?

When the pattern is not dentine sensitivity. The Oral Health Foundation lists severe pain, a single affected tooth, pain that starts suddenly and sensitivity lasting more than a few weeks as reasons to book an appointment²¹, and the NHS says toothache that goes on for more than two days, or comes with a high temperature, a bad taste or a swollen cheek, needs a dentist rather than a new toothpaste²².

Waiting is the right call for the slow, grinding, several-teeth kind of sensitivity that a desensitising paste is built for. It is the wrong call for a cracked tooth, and a cracked tooth does not care how long you have been brushing. The Journal has more on how to stop sensitive teeth pain in the meantime.